City Briefs: Tissue Regenix CEO back in action; “Exciting moment” for Provident suitor NSF; Sirius fundraising oversubscribed

The CEO of listed medtech company Tissue Regenix will be back in action in June.

Steve Couldwell stepped aside in January 2019 to undergo medical treatment for an unspecified condition.

John Samuel, chairman, Tissue Regenix Group plc: “The Board and I look forward to welcoming Steve back into the full time CEO position and are grateful for his ongoing commitment.

“During his necessary absence Steve remained in daily contact with the business and continued to be integral to implementing the business strategy and establishing future business developments, along with the support of Gareth Jones who undertook the chief operating officer role during this period.

“The business has continued to develop in line with the board expectations.”


Non-standard Finance, the suitor of Bradford subprime lender Provident Financial said the hostile takeover was an “exciting moment” for the group, despite not yet managing to obtain the full support of shareholders for the coup.

It said in an update this morning that it was working to fulfil conditions of the offer and was attempting to engage with shareholders at the Provident that had not yet accepted its offer.

It said: “This is an exciting moment for our Company. We have a clear transformation plan for the enlarged Group and are ready to start work on implementing it so that we can start to build a brighter future for all stakeholders.”


Sirius Minerals, the company behind the billion-pound Potash mine proposals for the North York Moors has said that its placing was oversubscribed.

In an update this morning, Sirius said that the firm placing and open offer to raise proceeds of US$425m (£327m), for the second stage of fundraising for the mine.

Chris Fraser, managing director and Sirius CEO said:”We are encouraged by the oversubscribed Open Offer, which underlines the strong equity market support for our comprehensive markets-led solution for stage 2 funding.

“Today’s result takes us another step closer to bringing POLY4 to the global agriculture industry and I would like to thank shareholders and partners for their continued support.

“We now turn our focus to delivering the next phase of the funding package, with planning for the high yield bond well underway.”